BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 17640156)

  • 1. Revisiting monoamine oxidase inhibitors.
    Krishnan KR
    J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of monoamine oxidase inhibitors in primary care.
    Culpepper L
    J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH
    J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA
    J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAOIs and depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAOIs: issues in treatment adherence and rates of treatment failure.
    Cohen LJ; Sclar DA
    J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel transdermal delivery formulation of the monoamine oxidase inhibitor selegiline nearing release for treatment of depression.
    Thase ME
    J Clin Psychiatry; 2006 Apr; 67(4):671-2. PubMed ID: 16669733
    [No Abstract]   [Full Text] [Related]  

  • 13. MAOIs and transdermal delivery.
    Vandenberg CM
    J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal selegiline: new opportunity for managing depression.
    Tobe EH
    J Am Osteopath Assoc; 2008 Feb; 108(2):85-6. PubMed ID: 18303066
    [No Abstract]   [Full Text] [Related]  

  • 16. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
    Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of MAOIs in primary care.
    Culpepper L
    J Clin Psychiatry; 2012 May; 73(5):e19. PubMed ID: 22697202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal selegiline: a novel MAOI formulation for depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2006 Jul; 44(7):9-12. PubMed ID: 17310829
    [No Abstract]   [Full Text] [Related]  

  • 20. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
    Fawcett J; Kravitz HM; Zajecka JM; Schaff MR
    J Clin Psychopharmacol; 1991 Apr; 11(2):127-32. PubMed ID: 2056139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.